Is Insulet Corporation (PODD) overvalued or fairly valued?

MarketChacha shows Insulet Corporation's valuation in context — a forward P/E of about 19.8, a price-to-book of about 8.5 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is the share price of Insulet Corporation (PODD)?

Insulet Corporation last traded at $159.24 (-2.7% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

Insulet Corporation

PODD · NASDAQ · Healthcare · United States

$159.24-2.7%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 5:37 PM

Snapshot

TickerPODD

ExchangeNASDAQ

SectorHealthcare

IndustryMedical Devices

CountryUnited States

Employees5,400

HeadquartersActon, United States

Market cap$11.0B

P/B8.5

Volume726.07K

Websitewww.insulet.com

Filings tracked0

About Insulet Corporation

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Profile as reported by Yahoo Finance.

Who owns it

Insiders0.3%
Institutions99.7%
Public & other0.0%

1,139 institutional holders

As reported by Yahoo Finance.

Top holders

Blackrock Inc.9.21%
Vanguard Capital Management LLC6.61%
FMR, LLC5.74%
Vanguard Portfolio Management LLC4.98%
State Street Corporation4.39%
BAILLIE GIFFORD & CO2.93%
Geode Capital Management, LLC2.92%
T. Rowe Price Investment Management, Inc.2.62%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

What's expected next

Next quarter

Rev $844.9M · EPS 1.63

Est. earnings growth +31.7%

Next fiscal year

Rev $3.9B · EPS 8.05

Est. earnings growth +24.3%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$138.7952-wk range$354.88

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Ask MarketChacha about PODD

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.